Skip to main content
SpringerLink
Log in

Unrevealing the natural course of the so-called “inactive HBsAg or HBV carrier state”

  • Editorial
  • Published:
Hepatology International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Alter HJ, Blumberg BS. Further studies on a “new” human isoprecipitin system (Australia antigen). Blood 1966;27:297–309

    PubMed  CAS  Google Scholar 

  2. Blumberg BS, Alter HJ, Visnich S. A “new” antigen in leukemia sera. JAMA 1965;191:541–6

    PubMed  CAS  Google Scholar 

  3. Blumberg BS, Sutnick AI, London WT. Hepatitis and leukemia: their relation to Australia antigen. Bull NY Acad Med 1968;44:1566–86

    CAS  Google Scholar 

  4. Prince AM. Relation of Australia and SH antigens. Lancet 1968;2:462–3

    Article  PubMed  CAS  Google Scholar 

  5. Dragosics B, Ferenci P, Hitchman E, Denk H. Long-term follow-up study of asymptomatic HBsAg-positive voluntary blood donors in Austria: a clinical and histologic evaluation of 242 cases. Hepatology 1987;7:302–6

    Article  PubMed  CAS  Google Scholar 

  6. Hadziyannis S, Merikas G, Panetsos S, Kourepi M. Hepatitis associated antigen carriers among blood donors in Greece. Am J Dis Child 1972;123:381–3

    PubMed  CAS  Google Scholar 

  7. Velasco M, Gonzalez-Ceron M, de la Fuente C, Ruiz A, Donoso S, Katz R. Clinical and pathological study of asymptomatic HBsAg carriers in Chile. Gut 1978;19:569–71

    PubMed  CAS  Google Scholar 

  8. Villeneuve JP, Desrochers M, Infante-Rivard C, Willems B, Raymond G, Bourcier M, et al. A long-term follow-up study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal. Gastroenterology 1994;106:1000–5

    PubMed  CAS  Google Scholar 

  9. Mushahwar IK, Overby LR, Frosner G, Deinhardt F, Ling CM. Prevalence of hepatitis B e antigen and its antibody as detected by radioimmunoassays. J Med Virol 1978;2:77–87

    Article  PubMed  CAS  Google Scholar 

  10. Hoofnagle JH. Type B hepatitis: virology, serology and clinical course. Semin Liver Dis 1981;1:7–14

    Article  PubMed  CAS  Google Scholar 

  11. Gudat F, Bianchi L, Sonnabend W, Thiel G, Aenishaenslin W, Stalder GA. Pattern of core and surface expression in liver tissue reflects state of specific immune response in hepatitis B. Lab Invest 1975;32:1–9

    PubMed  CAS  Google Scholar 

  12. Shafritz DA, Shouval D, Sherman HI, Hadziyannis SJ, Kew MC. Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens. N Engl J Med 1981;305:1067–73

    Article  PubMed  CAS  Google Scholar 

  13. Hadziyannis S, Gerber MA, Vissoulis C, Popper H. Cytoplasmic hepatitis B antigen in “ground-glass” hepatocytes of carriers. Arch Pathol 1973;96:327–30

    PubMed  CAS  Google Scholar 

  14. Hadziyannis SJ, Lieberman HM, Karvountzis GG, Shafritz DA. Analysis of liver disease, nuclear HBcAg, viral replication, and hepatitis B virus DNA in liver and serum of HBeAg Vs. anti-HBe positive carriers of hepatitis B virus. Hepatology 1983;3:656–62

    Article  PubMed  CAS  Google Scholar 

  15. Hadziyannis S, Raimondo G, Papaioannou C, Anastassakos C, Wong D, Sninsky J, et al. Expression of pre-S gene-encoded proteins in liver and serum during chronic hepatitis B virus infection in comparison to other markers of active virus replication. J Hepatol 1987;5:253–9

    Article  PubMed  CAS  Google Scholar 

  16. Hadziyannis SJ, Vassilopoulos D. Hepatitis B e antigen-negative chronic hepatitis B. Hepatology 2001;34:617–24

    Article  PubMed  CAS  Google Scholar 

  17. Carman WF, Jacyna MR, Hadziyannis S, Karayiannis P, McGarvey MJ, Makris A, et al. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 1989;2:588–91

    Article  PubMed  CAS  Google Scholar 

  18. Liaw YF, Leung N, Guan R, Lau GK, Merican I. Asian-Pacific consensus statement on the management of chronic hepatitis B: an update. J Gastroenterol Hepatol 2003;18:239–45

    Article  PubMed  Google Scholar 

  19. Keeffe EB, Dieterich DT, Han SH, Jacobson IM, Martin P, Schiff ER, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update. Clin Gastroenterol Hepatol 2006;4:936–62

    Article  PubMed  CAS  Google Scholar 

  20. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2007;45:507–39

    Article  PubMed  CAS  Google Scholar 

  21. Lok AS, Heathcote EJ, Hoofnagle JH. Management of hepatitis B: 2000—summary of a workshop. Gastroenterology 2001;120:1828–53

    Article  PubMed  CAS  Google Scholar 

  22. Lok AS, McMahon BJ. Chronic hepatitis B: update of recommendations. Hepatology 2004;39:857–61

    Article  PubMed  Google Scholar 

  23. Perrillo RP, Gish RG, Peters M, Keeffe EB, Alberti A, Buti M, et al. Chronic hepatitis B: a critical appraisal of current approaches to therapy. Clin Gastroenterol Hepatol 2006;4:233–48

    Article  PubMed  Google Scholar 

  24. Liaw YF, Leung N, Guan R, Lau GK, Merican I, McCaughan G, et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update. Liver Int 2005;25:472–89

    Article  PubMed  Google Scholar 

  25. Chu CM, Hung SJ, Lin J, Tai DI, Liaw YF. Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels. Am J Med 2004;116:829–34

    Article  PubMed  CAS  Google Scholar 

  26. Hsu YS, Chien RN, Yeh CT, Sheen IS, Chiou HY, Chu CM, et al. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology 2002;35:1522–7

    Article  PubMed  Google Scholar 

  27. Manesis EK, Papatheodoridis GV, Sevastianos V, Cholongitas E, Papaioannou C, Hadziyannis SJ. Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with hepatitis B e antigen-negative chronic hepatitis B virus infection. Am J Gastroenterol 2003;98:2261–7

    PubMed  CAS  Google Scholar 

  28. Manno M, Camma C, Schepis F, Bassi F, Gelmini R, Giannini F, et al. Natural history of chronic HBV carriers in northern Italy: morbidity and mortality after 30 years. Gastroenterology 2004;127:756–63

    Article  PubMed  Google Scholar 

  29. Evans AA, Chen G, Ross EA, Shen FM, Lin WY, London WT. Eight-year follow-up of the 90,000-person Haimen City cohort: I. Hepatocellular carcinoma mortality, risk factors, and gender differences. Cancer Epidemiol Biomarkers Prev 2002;11:369–76

    PubMed  Google Scholar 

  30. Beasley RP. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 1988;61:1942–56

    Article  PubMed  CAS  Google Scholar 

  31. Sakuma K, Takahara T, Okuda K, Tsuda F, Mayumi M. Prognosis of hepatitis B virus surface antigen carriers in relation to routine liver function tests: a prospective study. Gastroenterology 1982;83:114–7

    PubMed  CAS  Google Scholar 

  32. de Franchis R, Meucci G, Vecchi M, Tatarella M, Colombo M, Del Ninno E, et al. The natural history of asymptomatic hepatitis B surface antigen carriers. Ann Intern Med 1993;118:191–4

    PubMed  Google Scholar 

  33. Evans AA, O’Connell AP, Pugh JC, Mason WS, Shen FM, Chen GC, et al. Geographic variation in viral load among hepatitis B carriers with differing risks of hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev 1998;7:559–65

    PubMed  CAS  Google Scholar 

  34. Chu CM, Liaw YF. Spontaneous relapse of hepatitis in inactive HBsAg carriers from Taiwan. Hepatol Intl 2007; doi: 10.1007/s12072-007-9002-9

Download references

Author information

Authors and Affiliations

  1. Department of Medicine and Hepatology, Henry Dunant Hospital, 107 Messogion Ave., Athens, 115 26, Greece

    Stephanos J. Hadziyannis

Authors
  1. Stephanos J. Hadziyannis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stephanos J. Hadziyannis.

Additional information

See DOI: 10.1007/s12072-007-9002-9

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hadziyannis, S.J. Unrevealing the natural course of the so-called “inactive HBsAg or HBV carrier state”. Hep Intl 1, 281–284 (2007). https://doi.org/10.1007/s12072-007-9004-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12072-007-9004-7

Search

Navigation